Insulin increases distinct species of 1,2-diacylglycerol in isolated perfused rat heart

被引:9
作者
Okumura, K
Matsui, H
Murase, K
Shimauchi, A
Shimizu, K
Toki, Y
Ito, T
Hayakawa, T
机构
[1] Second Dept. of Internal Medicine, Nagoya University, School of Medicine, Nagoya
[2] Second Dept. of Internal Medicine, Nagoya University, School of Medicine, Showa-ku, Nagoya 466
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1996年 / 45卷 / 06期
关键词
D O I
10.1016/S0026-0495(96)90145-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin and glucose increase the synthesis of 1,2-diacylglycerol (1,2-DAG), the physiological activator of protein kinase C (PKC) in a variety of tissues and cells. The effects of insulin and glucose on the abundance and fatty acid composition of 1,2-DAG were investigated in isolated perfused rat hearts with the use of capillary gas chromatography and 1,2-dipentadecanoin as an internal standard. A high concentration of insulin (25 mU/mL) significantly increased cardiac contractility and reduced coronary flow. in addition, perfusion with 25 mU/mL insulin induced significant increases of 18.2% and 26.4% in 1,2-DAG mass after 5 and 30 minutes, respectively, in the presence of 8.6 mmol/L glucose, whereas there was no increase in 1,2-DAG with 2.5 mU/mL insulin. Analysis of the fatty acid composition of 1,2-DAG showed that only species containing specific fatty acids (16:0, 18:1, and 18:2) were increased in response to insulin. In contrast, an increase in glucose concentration in the perfusion medium from 3 to 17 mmol/L had no effect on the total mass or fatty acid composition of 1,2-DAG, cardiac contractility, or coronary flow. Addition of a high insulin concentration to the high-glucose medium increased the abundance of 1,2-DAG containing 16:0, 18:1, and 18:2 fatty acids, as well as cardiac contractility. It is concluded that the effect of insulin on cardiac contractility may be related to the associated increase in 1,2-DAG abundance. Copyright (C) 1996 by W.B. Saunders Company.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 43 条
[1]   HIGH GLUCOSE INCREASES DIACYLGLYCEROL MASS AND ACTIVATES PROTEIN-KINASE-C IN MESANGIAL CELL-CULTURES [J].
AYO, SH ;
RADNIK, R ;
GARONI, JA ;
TROYER, DA ;
KREISBERG, JI .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (04) :F571-F577
[2]   INSULIN ADMINISTRATION INVIVO INCREASES 1,2-DIACYLGLYCEROL IN RAT SKELETAL-MUSCLE [J].
BOGGS, KP ;
FARESE, RV ;
BUSE, MG .
ENDOCRINOLOGY, 1991, 128 (01) :636-638
[3]   EFFECT OF INSULIN ON SN-1,2-DIACYLGLYCEROL SPECIES AND DE-NOVO SYNTHESIS IN RAT SKELETAL-MUSCLE [J].
BOGGS, KP ;
BUSE, MG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (03) :348-357
[4]   LIPID ACTIVATORS OF PROTEIN-KINASE-C [J].
CHAUHAN, VPS ;
CHAUHAN, A ;
DESHMUKH, DS ;
BROCKERHOFF, H .
LIFE SCIENCES, 1990, 47 (12) :981-986
[5]   INSULIN INCREASES A BIOCHEMICALLY DISTINCT POOL OF DIACYLGLYCEROL IN THE RAT SOLEUS MUSCLE [J].
CHEN, KS ;
HEYDRICK, SJ ;
BROWN, ML ;
FRIEL, JC ;
RUDERMAN, NB .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (03) :E479-E485
[6]   INSULIN-STIMULATED HYDROLYSIS OF PHOSPHATIDYLCHOLINE BY PHOSPHOLIPASE-C AND PHOSPHOLIPASE-D IN CULTURED RAT HEPATOCYTES [J].
DONCHENKO, V ;
ZANNETTI, A ;
BALDINI, PM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1222 (03) :492-500
[7]   INSULIN AND GLUCOSE MODULATE PROTEIN KINASE-C ACTIVITY IN RAT ADIPOCYTES [J].
DRAZNIN, B ;
LEITNER, JW ;
SUSSMAN, KE ;
SHERMAN, NA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :570-575
[8]   PANCREATIC-ISLETS SYNTHESIZE PHOSPHOLIPIDS DENOVO FROM GLUCOSE VIA ACYL-DIHYDROXYACETONE PHOSPHATE [J].
DUNLOP, ME ;
LARKINS, RG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 132 (02) :467-473
[9]   THE ACTIONS OF INSULIN ON CARDIAC CONTRACTILITY [J].
FARAH, AE ;
ALOUSI, AA .
LIFE SCIENCES, 1981, 29 (10) :975-1000
[10]   PREFERENTIAL ACTIVATION OF MICROSOMAL DIACYLGLYCEROL/PROTEIN KINASE-C SIGNALING DURING GLUCOSE TREATMENT (DE-NOVO PHOSPHOLIPID-SYNTHESIS) OF RAT ADIPOCYTES [J].
FARESE, RV ;
STANDAERT, ML ;
ARNOLD, TP ;
YAMADA, K ;
MUSUNURU, K ;
HERNANDEZ, H ;
MISCHAK, H ;
COOPER, DR .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :1894-1899